Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 6.


De Caterina, Raffaele, Procopio, Antonio, Lopez Sendon, Jose-Luis, Raev, Dimitar, Mehta, Shamir R, Opolski, Grzegorz, Oldgren, Jonas, Steg, Philippe Gabriel, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626
et al (show 7 more authors) (2020) Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI. AMERICAN JOURNAL OF MEDICINE, 133 (11). pp. 1302-1312.


ten Berg, Jurrien M, Steg, Philippe Gabriel, Bhatt, Deepak L, Hohnloser, Stefan H, de Veer, Anne, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Oldgren, Jonas
et al (show 1 more authors) (2020) Comparison of the Effect of Age (&lt; 75 Versus ≥75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial). AMERICAN JOURNAL OF CARDIOLOGY, 125 (5). pp. 735-743.


Oldgren, Jonas, Steg, Philippe Gabriel, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Kimura, Takeshi, Nordaby, Matias, Brueckmann, Martina, Kleine, Eva, ten Berg, Jurrien M, Bhatt, Deepak L
et al (show 1 more authors) (2019) Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. EUROPEAN HEART JOURNAL, 40 (19). 1553-+.


Berry, Natalia C, Mauri, Laura, Steg, Philippe Gabriel, Bhatt, Deepak L, Hohnloser, Stefan H, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Oldgren, Jonas
et al (show 2 more authors) (2020) Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention A Subgroup Analysis From the REDUAL PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 13 (4). e008349-.


Peterson, Benjamin E, Bhatt, Deepak L, Steg, Ph Gabriel, Oldgren, Jonas, Maeng, Michael, Zeymer, Uwe, Halvorsen, Sigrun, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Kimura, Takeshi
et al (show 5 more authors) (2021) Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial. JACC-CARDIOVASCULAR INTERVENTIONS, 14 (7). pp. 768-780.


Eccleston, David S, Kim, Joseph M, ten Berg, Jurien M, Steg, P Gabriel, Bhatt, Deepak L, Hohnloser, Stefan H, de Veer, Anne, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi
et al (show 3 more authors) (2021) The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials). CLINICAL CARDIOLOGY, 44 (7). pp. 1002-1010.

This list was generated on Mon Apr 15 02:06:06 2024 BST.